For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240917:nRSQ5694Ea&default-theme=true
RNS Number : 5694E Spire Healthcare Group PLC 17 September 2024
17 September 2024
Spire Healthcare Group plc (the "Company" or "Spire Healthcare")
Acquisition of Spire Healthcare shares by a Spire Healthcare Director
The following Spire Healthcare Director has purchased ordinary shares in the
Company as follows:
Director Position Shares purchased Date of purchase Price Holding post announcement
Justin Ash Chief Executive Officer 21,100 17 September 2024 236.25 pence 848,740
Enquiries:
Mantraraj Budhdev
Group General Counsel and Company Secretary
+44 7787 283848
Notification and public disclosure of transaction by persons discharging
managerial responsibility and persons closely associated with them
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Justin Ash
2 Reason for the notification
a) Position/status Chief Executive Officer and Executive Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Purchase of 21,100 ordinary shares at 236.25 pence each
c) Price(s) and volume(s) Price(s) Volume(s)
236.25 pence 21,100
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2024-09-17
f) Place of the transaction XLON
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBSGDCISBDGSR